Correlation Engine 2.0
Clear Search sequence regions


The conclusions of a recent study of mitoxantrone (Novantrone) in multiple sclerosis and the approval of several health authorities support its use in patients with active relapsing-remitting or secondary progressive multiple sclerosis. This drug profile provides an outline on relevant preclinical and clinical studies, discusses relevant side effects of the compound and places mitoxantrone in the context of other therapeutic approaches available against this disabling disorder.

Citation

Oliver Neuhaus, Bernd C Kieseier, Hans-Peter Hartung. Mitoxantrone (Novantrone) in multiple sclerosis: new insights. Expert review of neurotherapeutics. 2004 Jan;4(1):17-26

Expand section icon Mesh Tags

Expand section icon Substances


PMID: 15853611

View Full Text